Nisa Investment Advisors’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.9K | Sell |
780
-42
| -5% | -$1.4K | ﹤0.01% | 1815 |
|
2025
Q1 | $24.1K | Sell |
822
-14
| -2% | -$410 | ﹤0.01% | 1807 |
|
2024
Q4 | $27.5K | Buy |
836
+127
| +18% | +$4.17K | ﹤0.01% | 1842 |
|
2024
Q3 | $31.5K | Sell |
709
-140
| -16% | -$6.22K | ﹤0.01% | 1766 |
|
2024
Q2 | $36.6K | Buy |
849
+58
| +7% | +$2.5K | ﹤0.01% | 1753 |
|
2024
Q1 | $23.1K | Buy |
791
+41
| +5% | +$1.2K | ﹤0.01% | 1842 |
|
2023
Q4 | $16.7K | Sell |
750
-1
| -0.1% | -$22 | ﹤0.01% | 1927 |
|
2023
Q3 | $18.6K | Hold |
751
| – | – | ﹤0.01% | 2043 |
|
2023
Q2 | $21.3K | Buy |
751
+266
| +55% | +$7.53K | ﹤0.01% | 2076 |
|
2023
Q1 | $11K | Sell |
485
-1,300
| -73% | -$29.5K | ﹤0.01% | 2141 |
|
2022
Q4 | $50K | Hold |
1,785
| – | – | ﹤0.01% | 1764 |
|
2022
Q3 | $49K | Buy |
1,785
+45
| +3% | +$1.24K | ﹤0.01% | 1741 |
|
2022
Q2 | $39K | Buy |
1,740
+1,300
| +295% | +$29.1K | ﹤0.01% | 1812 |
|
2022
Q1 | $13K | Sell |
440
-1,270
| -74% | -$37.5K | ﹤0.01% | 2144 |
|
2021
Q4 | $53K | Sell |
1,710
-1,120
| -40% | -$34.7K | ﹤0.01% | 1717 |
|
2021
Q3 | $131 | Hold |
2,830
| – | – | ﹤0.01% | 1581 |
|
2021
Q2 | $156 | Buy |
2,830
+30
| +1% | +$2 | ﹤0.01% | 1498 |
|
2021
Q1 | $145 | Buy |
2,800
+2,200
| +367% | +$114 | ﹤0.01% | 1591 |
|
2020
Q4 | $26K | Sell |
600
-1,858
| -76% | -$80.5K | ﹤0.01% | 2087 |
|
2020
Q3 | $86K | Buy |
2,458
+1,858
| +310% | +$65K | ﹤0.01% | 1585 |
|
2020
Q2 | $32K | Hold |
600
| – | – | ﹤0.01% | 1669 |
|
2020
Q1 | $21K | Buy |
+600
| New | +$21K | ﹤0.01% | 1697 |
|
2019
Q1 | – | Sell |
-4,642
| Closed | -$214K | – | 2031 |
|
2018
Q4 | $214K | Hold |
4,642
| – | – | ﹤0.01% | 1223 |
|
2018
Q3 | $358K | Buy |
+4,642
| New | +$358K | ﹤0.01% | 1188 |
|
2016
Q2 | – | Sell |
-200
| Closed | -$8K | – | 1859 |
|
2016
Q1 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 1801 |
|